Pharmeasy-parent’s loss narrows in Q1, revenue up 10%

API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while revenue grew 10% to Rs 1,754 crore. Ebitda turned positive at Rs 39.3 crore. The company also became debt-free after repaying Rs 1,050 crore.

Related Stories

Foxconn says third quarter to outperform market expectations on AI strength

Taiwan flexes chip diplomacy muscles as it faces pressure to share AI wealth with allies

Can dogs sniff cancer? AI joins the hunt in India

“Time calls for extreme caution”, warns OpenAI chief scientist, pushing for broader interventions as AI capabilities surge